Crossmark

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers

Published Online: 2022-06-07

Published Print: 2022-06

Authors

Nath, Aritro https://orcid.org/0000-0002-3225-4203
Cohen, Adam L

Bild, Andrea H https://orcid.org/0000-0003-4850-0453
Funding

Funding for this research was provided by:

National Cancer Institute (1U54CA209978)
License Information

Version of Record valid from 2022-06-07
More Information

Publication History

Received: 2021-11-17

Accepted: 2022-05-20

Published: 2022-06-07

Document is current